$169/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included.
Get startedHome / Research peptides vs. compounded GLP-1s
Cheap powder isn’t a prescription.
Buying tirzepatide peptides online? What “research use only” really means (2026)
“Research use only” tirzepatide isn’t made for people: no prescription, no physician, no pharmacy label, and the FDA has warned sellers. A compounded GLP-1 is prepared by a state-licensed pharmacy for your prescription. At NexLife, that’s $169 a month, matched if you pay less†, for tirzepatide at every dose, all in.
- Research use only: not for people
- Prescribed: a physician and a licensed pharmacy
- NexLife: $169, every dose
Published by NexLifeLegitScript-certifiedUpdated October 9, 2026Medically reviewed by the NexLife clinical team, led by Adam Kennah, MD (NPI 1144260043)
Research peptides, in short
- Made for people?
- No: “for research use only”
- Prescription or review?
- None
- Label you can trust?
- No strength or directions for you
- The FDA’s view
- It has warned sellers; quality unknown
- The prescribed route
- $169 a month at NexLife, every dose, all in
Questions about something you saw online? Call or text (949) 818-8000, 24/7.
Start with tirzepatide, $169/mo
4.8 out of 5 on Trustpilot · LegitScript certified
The difference
Side by side
| Prescribed, compounded GLP-1 | “Research use only” peptide | |
|---|---|---|
| Prescription | Required, for you | None |
| Health review | A licensed physician reviews your history | None |
| Who prepares it | A state-licensed pharmacy | A seller outside the pharmacy system |
| Label | Your name, the strength, directions, a beyond-use date and storage | “For research use only” or “not for human consumption” |
| Dosing | Your provider sets it and follows it | You mix powder and measure it yourself |
| Someone to call | At NexLife, one number, 24/7: (949) 818-8000 | No one with a duty to your care |
| FDA-approved? | No | No |
Compounded medications aren’t FDA-approved, and the FDA doesn’t review them for safety, effectiveness or quality before they’re sold.
The warnings
What the FDA says
Falsely labeled products. The FDA has warned companies that sold GLP-1 drugs labeled “for research purposes” or “not for human consumption” while marketing them to people with dosing directions.
Unknown quality. The FDA says illegally marketed semaglutide and tirzepatide could be counterfeit, contain the wrong ingredients, or have the wrong dose.
Retatrutide and cagrilintide. Neither is FDA-approved for any condition, and neither can be used in compounding under federal law.
Stopped at the border. An FDA import alert keeps GLP-1 ingredients from makers that haven’t shown compliance out of the U.S. supply.
Real medicine has a name on the label.
A prescription comes with a physician, a pharmacy and a label. A research peptide comes with none of them.
- Shortcuts tempt. Low prices and no paperwork can look like a deal.
- Labels mislead. “Research use only” means not for people.
- Quality is unknown. No one checks what’s really inside.
A physician who decides. A pharmacy you can name.
- A physician decides. A licensed physician reviews your history before anything is prescribed.
- One flat price. $169 tirzepatide, $139 semaglutide, at every dose.
- Named pharmacies. State-licensed pharmacies, named on NexLife’s plan pages.
Real people, real answers. Call or text (949) 818-8000 with any question about a product you’ve seen online.
Check my eligibility, $169/mo
The dose math
What “30 mg tirzepatide” really means
“30 mg” is the whole vial, not a dose. Research peptides are often sold as powder by the vial. You’d add liquid yourself and work out the dose.
That math is where errors happen. Even with prescriptions and labeled vials, the FDA has received reports of dosing errors with compounded semaglutide. Mixing your own powder adds another step to get wrong.
A prescription removes the guesswork. Your label shows the strength in mg per mL, and your provider tells you your dose in milligrams.
Checklist
How to tell a prescription from a research peptide
- A licensed physician reviewed your health history before anything was sold
- The label names a state-licensed pharmacy, your name, the strength and directions
- There’s a beyond-use date and storage directions
- Someone answers when you call with a question
Two medications.
One flat price each.
Both are prepared by state-licensed 503A partner pharmacies and shipped free. Your provider helps you decide which one fits.
$139/mo
Semaglutide
Weekly GLP-1. Care, coaching and shipping included.
Get startedWhat’s inside every plan
- Tirzepatide: compounded, acts on two hormone pathways (GIP and GLP-1), taken once a week
- Semaglutide: compounded, acts on the GLP-1 pathway, taken once a week
- Prepared by state-licensed 503A partner pharmacies
- A licensed provider who reviews your history and follows your dose
- A personalized nutrition plan and a 1:1 coaching call
- Free expedited shipping; orders usually ship within 1 to 2 business days
- 24/7 support from real people, plus physician access during clinical hours
- HSA and FSA cards accepted, and Klarna or Afterpay at checkout
- Prefer no injections? Ask about the sublingual tablet, at its own flat price
Prescription required. Compounded medications are not FDA-approved. On 12-month plans: $139 a month for tirzepatide, $119 for semaglutide, still the same at every dose. Prices checked October 7–8, 2026.
Your dose goes up.
Your price doesn’t.
No membership, no dose surcharges, no surprises. One flat, all-inclusive monthly price at every dose.
| Month one | Month two | Month three | Every month after | |
|---|---|---|---|---|
| Tirzepatide | $169 | $169 | $169 | $169 |
| Semaglutide | $139 | $139 | $139 | $139 |
Paying less somewhere else? Send us a receipt from another licensed U.S. telehealth provider and we’ll match your regular monthly price. See the terms
Month-to-month plan, all-inclusive. Longer plans cost less and stay flat. Tirzepatide is $159, $149 and $139 a month on 3-, 6- and 12-month plans. Semaglutide is $132, $125 and $119.
What would you pay with NexLife?
Tap where you are now. We’ll show your NexLife price next to it, or tell you we’ll match it.
Pick one above to see your price.
Not today?
Prices from each provider, checked October 7–8, 2026. Brand-name and compounded medications are different products; compounded medications are not FDA-approved. †Price Match Guarantee terms apply.
The NexLife Price Match Guarantee
Keep your price.
Upgrade your care.
Already on compounded tirzepatide or semaglutide? Bring your price to NexLife. If you pay less with another licensed U.S. telehealth provider, we match your regular monthly price for as long as your plan stays active.† You keep your price, and you gain a provider who follows your dose, a personal nutrition plan, a 1:1 coaching call and real people who answer 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†NexLife Price Match Guarantee: for new members switching from a licensed U.S. telehealth provider with an active prescription for compounded tirzepatide or semaglutide. Send a receipt from the last 60 days and we match your regular all-in monthly price on the month-to-month plan, for the same medication (medication plus required fees; not first-month offers, coupons or prepaid multi-month rates), for as long as your plan stays active. A NexLife provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
The prescribed route, at a fair price
All of this comes with one monthly price, at every dose.
- A licensed providerReviews your history, prescribes only if it’s right for you, and follows your dose.
- Real people, 24/7Call or text (949) 818-8000 any time. Physicians answer medical questions during clinical hours.
- Nutrition plan and coachingA personalized nutrition plan and a 1:1 coaching call.
- Named partner pharmaciesState-licensed 503A pharmacies, LegitScript-certified and NABP-accredited.
- Free expedited shippingOrders usually ship within 1 to 2 business days, discreetly packed.
- Pay your wayHSA and FSA cards, plus Klarna or Afterpay at checkout.
Saw something online? Ask us first.
Call or text (949) 818-8000, 24/7. Real people answer, with no pressure and no judgment.
Research peptides: your questions
Are research peptides legal to buy?
Selling GLP-1 drugs labeled “for research use only” to people is illegal, and the FDA has warned companies that do it. They aren’t made or checked for human use.
Is research tirzepatide the same as compounded tirzepatide?
No. Compounded tirzepatide is prepared by a state-licensed pharmacy for your prescription. A research peptide has no prescription, no pharmacy and no label you can rely on.
What does “30 mg tirzepatide” mean?
Usually the total amount of powder in a vial, not a dose. Doses of prescribed tirzepatide range from 2.5 mg to 15 mg a week.
Can I get retatrutide?
Not legitimately. It isn’t FDA-approved for any condition and can’t be used in compounding under federal law.
Why are research peptides cheaper?
No physician, no licensed pharmacy, no testing you can verify, and no one to call. That’s what the lower price leaves out.
I’ve used a research peptide. What should I do?
Tell a licensed provider what you took and how much. You can call or text us at (949) 818-8000, 24/7, and report problems to the FDA’s MedWatch program.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.
Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and depression or thoughts of suicide. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.
Tirzepatide can make birth control pills less effective: use another method for 4 weeks after you start and after each dose increase. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
Who checked this page
Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine · NPI 1144260043
Leads the NexLife clinical team, which medically reviewed this page on October 8, 2026.
NexLife editorial teamResearch and pricing
the FDA’s warnings on falsely labeled GLP-1s, retatrutide and imports, and how prescribed compounding works
- Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth provider. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.
A real prescription. A fair price.
Start online in about 3 minutes. A licensed physician decides if treatment is right for you.
- 1Tell us about you
A short online health assessment, about 3 minutes.
- 2A licensed provider reviews it
You’re prescribed only if treatment is right for you.
- 3We ship it, then stay with you
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, 24/7 support.
Sources
- U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss.
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers.
- U.S. Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.
- U.S. Food and Drug Administration. MedWatch: report a problem.
- NexLife. Compounded tirzepatide plans.
- NexLife. Compounded semaglutide plans.
- Eli Lilly and Company. Zepbound (tirzepatide) prescribing information.
- Novo Nordisk. Wegovy (semaglutide) prescribing information.
- LegitScript. Certification lookup for nexlife.us.